Completed NA INTERVENTIONAL 2-arm NCT00122135

A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making (Aim3)

Sponsor: Baylor College of Medicine

Conditions Chronic Kidney Disease Chronic Obstructive Pulmonary Disease Cirrhosis Colon Carcinoma Congestive Heart Failure Lung Cancer

Interventions Values Inventory (VI)

Updated 6 times since 2017 Last updated: Nov 16, 2015 Started: Dec 31, 2004 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00122135, this NA trial focuses on Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease and remains completed. Sponsored by Baylor College of Medicine, it has been updated 6 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor College of Medicine
VA Office of Research and Development

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States